Global Fragile X Syndrome Market and Competitive Landscape – 2017

1. Fragile X Syndrome: Disease Overview

1.1. Fragile X Syndrome Symptoms

1.2. Fragile X Syndrome Etiology

1.3. Fragile X Syndrome Diagnosis

1.4. Fragile X Syndrome Treatment Options

2. Fragile X Syndrome Pipeline Insights

2.1. Fragile X Syndrome Phase 3 Clinical Trials

2.2. Fragile X Syndrome Phase 2 Clinical Trials

2.3. Fragile X Syndrome Phase 1 Clinical Trials

3. Fragile X Syndrome Epidemiology Analysis

4. US Fragile X Syndrome Market Insights

4.1. Marketed Products for Fragile X Syndrome in US

4.2. US Fragile X Syndrome Market Size & Forecast

4.3. US Fragile X Syndrome Product Sales Forecast

4.4. US Fragile X Syndrome Market Share Analysis

5. Germany Fragile X Syndrome Market Insights

5.1. Marketed Products for Fragile X Syndrome in Germany

5.2. Germany Fragile X Syndrome Market Size & Forecast

5.3. Germany Fragile X Syndrome Product Sales Forecast

5.4. Germany Fragile X Syndrome Market Share Analysis

6. France Fragile X Syndrome Market Insights

6.1. Marketed Products for Fragile X Syndrome in France

6.2. France Fragile X Syndrome Market Size & Forecast

6.3. France Fragile X Syndrome Product Sales Forecast

6.4. France Fragile X Syndrome Market Share Analysis

7. Italy Fragile X Syndrome Market Insights

7.1. Marketed Products for Fragile X Syndrome in Italy

7.2. Italy Fragile X Syndrome Market Size & Forecast

7.3. Italy Fragile X Syndrome Product Sales Forecast

7.4. Italy Fragile X Syndrome Market Share Analysis

8. Spain Fragile X Syndrome Market Insights

8.1. Marketed Products for Fragile X Syndrome in Spain

8.2. Spain Fragile X Syndrome Market Size & Forecast

8.3. Spain Fragile X Syndrome Product Sales Forecast

8.4. Spain Fragile X Syndrome Market Share Analysis

9. UK Fragile X Syndrome Market Insights

9.1. Marketed Products for Fragile X Syndrome in UK

9.2. UK Fragile X Syndrome Market Size & Forecast

9.3. UK Fragile X Syndrome Product Sales Forecast

9.4. UK Fragile X Syndrome Market Share Analysis

10. Europe Fragile X Syndrome Market Insights

10.1. Europe Fragile X Syndrome Market Size & Forecast

10.2. Europe Fragile X Syndrome Product Sales Forecast

10.3. Europe Fragile X Syndrome Market Share Analysis

11. Japan Fragile X Syndrome Market Insights

11.1. Marketed Products for Fragile X Syndrome in Japan

11.2. Japan Fragile X Syndrome Market Size & Forecast

11.3. Japan Fragile X Syndrome Product Sales Forecast

11.4. Japan Fragile X Syndrome Market Share Analysis

12. Global Fragile X Syndrome Market Insights

12.1. Global Fragile X Syndrome Market Size & Forecast

12.2. Global Fragile X Syndrome Product Sales Forecast

12.3. Global Fragile X Syndrome Market Share Analysis

13. Research Methodology

LIST OF TABLES

Table 1: Fragile X Syndrome Phase 3 Clinical Trials, Global, 2017

Table 2: Fragile X Syndrome Phase 2 Clinical Trials, Global, 2017

Table 3: Fragile X Syndrome Phase 1 Clinical Trials, Global, 2017

Table 4: Fragile X Syndrome Prevalence by G7 Countries, 2012 - 2021

Table 5: Marketed Products for Fragile X Syndrome in US, 2017

Table 6: US Fragile X Syndrome Market Size & Forecast ($mn), 2012 - 2021

Table 7: US Fragile X Syndrome Product Sales ($mn), 2012 - 2021

Table 8: US Fragile X Syndrome Market Trends, 2012 - 2021

Table 9: Marketed Products for Fragile X Syndrome in Germany, 2017

Table 10: Germany Fragile X Syndrome Market Size & Forecast ($mn), 2012 - 2021

Table 11: Germany Fragile X Syndrome Product Sales ($mn), 2012 - 2021

Table 12: Germany Fragile X Syndrome Market Trends, 2012 - 2021

Table 13: Marketed Products for Fragile X Syndrome in France, 2017

Table 14: France Fragile X Syndrome Market Size & Forecast ($mn), 2012 - 2021

Table 15: France Fragile X Syndrome Product Sales ($mn), 2012 - 2021

Table 16: France Fragile X Syndrome Market Trends, 2012 - 2021

Table 17: Marketed Products for Fragile X Syndrome in Italy, 2017

Table 18: Italy Fragile X Syndrome Market Size & Forecast ($mn), 2012 - 2021

Table 19: Italy Fragile X Syndrome Product Sales ($mn), 2012 - 2021

Table 20: Italy Fragile X Syndrome Market Trends, 2012 - 2021

Table 21: Marketed Products for Fragile X Syndrome in Spain, 2017

Table 22: Spain Fragile X Syndrome Market Size & Forecast ($mn), 2012 - 2021

Table 23: Spain Fragile X Syndrome Product Sales ($mn), 2012 - 2021

Table 24: Spain Fragile X Syndrome Market Trends, 2012 - 2021

Table 25: Marketed Products for Fragile X Syndrome in UK, 2017

Table 26: UK Fragile X Syndrome Market Size & Forecast ($mn), 2012 - 2021

Table 27: UK Fragile X Syndrome Product Sales ($mn), 2012 - 2021

Table 28: UK Fragile X Syndrome Market Trends, 2012 - 2021

Table 29: Europe Fragile X Syndrome Market Size & Forecast ($mn), 2012 - 2021

Table 30: Europe Fragile X Syndrome Product Sales ($mn), 2012 - 2021

Table 31: Marketed Products for Fragile X Syndrome in Japan, 2017

Table 32: Japan Fragile X Syndrome Market Size & Forecast ($mn), 2012 - 2021

Table 33: Japan Fragile X Syndrome Product Sales ($mn), 2012 - 2021

Table 34: Japan Fragile X Syndrome Market Trends, 2012 - 2021

Table 35: Global Fragile X Syndrome Market Size & Forecast ($mn), 2012 - 2021

Table 36: Global Fragile X Syndrome Product Sales ($mn), 2012 - 2021

LIST OF FIGURES

Figure 1: Fragile X Syndrome Pipeline by Phase (%), Global, 2017

Figure 2: Fragile X Syndrome Prevalence by G7 Countries, 2012 - 2021

Figure 3: US Fragile X Syndrome Market Size ($mn), 2012 - 2021

Figure 4: US Fragile X Syndrome Product Sales ($mn), 2012 - 2021

Figure 5: US Fragile X Syndrome Market Share by Products (%), 2016

Figure 6: US Fragile X Syndrome Market - Future Market Share (%), 2021

Figure 7: Germany Fragile X Syndrome Market Size ($mn), 2012 - 2021

Figure 8: Germany Fragile X Syndrome Product Sales ($mn), 2012 - 2021

Figure 9: Germany Fragile X Syndrome Market Share by Products (%), 2016

Figure 10: Germany Fragile X Syndrome Market - Future Market Share (%), 2021

Figure 11: France Fragile X Syndrome Market Size ($mn), 2012 - 2021

Figure 12: France Fragile X Syndrome Product Sales ($mn), 2012 - 2021

Figure 13: France Fragile X Syndrome Market Share by Products (%), 2016

Figure 14: France Fragile X Syndrome Market - Future Market Share (%), 2021

Figure 15: Italy Fragile X Syndrome Market Size ($mn), 2012 - 2021

Figure 16: Italy Fragile X Syndrome Product Sales ($mn), 2012 - 2021

Figure 17: Italy Fragile X Syndrome Market Share by Products (%), 2016

Figure 18: Italy Fragile X Syndrome Market - Future Market Share (%), 2021

Figure 19: Spain Fragile X Syndrome Market Size ($mn), 2012 - 2021

Figure 20: Spain Fragile X Syndrome Product Sales ($mn), 2012 - 2021

Figure 21: Spain Fragile X Syndrome Market Share by Products (%), 2016

Figure 22: Spain Fragile X Syndrome Market - Future Market Share (%), 2021

Figure 23: UK Fragile X Syndrome Market Size ($mn), 2012 - 2021

Figure 24: UK Fragile X Syndrome Product Sales ($mn), 2012 - 2021

Figure 25: UK Fragile X Syndrome Market Share by Products (%), 2016

Figure 26: UK Fragile X Syndrome Market - Future Market Share (%), 2021

Figure 27: Europe Fragile X Syndrome Market Size ($mn), 2012 - 2021

Figure 28: Europe Fragile X Syndrome Product Sales ($mn), 2012 - 2021

Figure 29: Europe Fragile X Syndrome Market Share by Products (%), 2016

Figure 30: Europe Fragile X Syndrome Market - Future Market Share (%), 2021

Figure 31: Japan Fragile X Syndrome Market Size ($mn), 2012 - 2021

Figure 32: Japan Fragile X Syndrome Product Sales ($mn), 2012 - 2021

Figure 33: Japan Fragile X Syndrome Market Share by Products (%), 2016

Figure 34: Japan Fragile X Syndrome Market - Future Market Share (%), 2021

Figure 35: Global Fragile X Syndrome Market Size ($mn), 2012 - 2021

Figure 36: Global Fragile X Syndrome Product Sales ($mn), 2012 - 2021

Figure 37: Global Fragile X Syndrome Market Share by Products (%), 2016

Figure 38: Global Fragile X Syndrome Market - Future Market Share (%), 2021

Global Fragile X Syndrome Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Global Fragile X Syndrome Market and Competitive Landscape – 2017, provides comprehensive insights into Fragile X Syndrome pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Fragile X Syndrome market size and drug sales. This research also provides insights into Fragile X Syndrome epidemiology and late stage pipeline.
The report is classified into twelve sections – Fragile X Syndrome overview with definitions, symptoms, etiology, diagnosis, treatment options; Fragile X Syndrome pipeline insights covering late stage clinical trials pipeline; Fragile X Syndrome prevalence trends by countries; Fragile X Syndrome market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries – US, Germany, France, Italy, Spain, UK, Japan, Europe, Global.

Research Scope:

• Fragile X Syndrome pipeline: Find out the drugs in clinical trials for Fragile X Syndrome by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
• Fragile X Syndrome epidemiology: Find out the prevalence of Fragile X Syndrome by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
• Fragile X Syndrome products: Identify key products marketed and prescribed for Fragile X Syndrome by brand name, by molecule, by company, by branded / generic, by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
• Fragile X Syndrome market size: Find out the market size for Fragile X Syndrome drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
• Fragile X Syndrome drug sales: Find out the sales of Fragile X Syndrome drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
• Fragile X Syndrome drugs sales forecast: Sales forecast for Fragile X Syndrome drugs to 2021 by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
• Fragile X Syndrome market share analysis: Find out the market shares of Fragile X Syndrome drugs and outlook by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan

Benefits of this Research: The research helps executives to

• Evaluate commercial market opportunities for Fragile X Syndrome drugs
• Synthesize insights for business development & licensing
• Track market size, competitor drug sales, market shares in Fragile X Syndrome market
• Develop in-depth knowledge of competition and markets
• Analyze sales data to update your brand planning trackers
• Develop tactics and strategies to take advantage of opportunities in the market
• Track market trends and analyze key events in Fragile X Syndrome market
• Develop forecast models, healthcare frameworks, or economic models
• Answer key business questions; supports decision making in R&D to long term marketing strategies